Friday, April 29, 2011

The Death of Pharmaceutical Rep Detailing?

Media_httpwwwinnovati_hbsqh

We know, for example, that ten years ago, there were about 40% more detailing representatives than there are now. The doctor-to-rep ratio has gone from 6-to-1 to 10-to-1. At the same time, as we are seeing doctors decreasing access, there is quite a bit of evidence that when a doctor sees a rep, it is for less time – in our surveys, we see a little more than half of the consummated discussions last four minutes or less.

Posted via email from Jack's posterous

No comments: